Competitor Poised to Take on Obesity Treatment Giant Wegovy in 2023
In this report, we follow up on what's happened since this approval and what's next.
The FDA green-lit tirzepatide...
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news
More News: Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Obesity | Urology & Nephrology